Qlaris Phase 2 Study in NTG Patients
Conditions: Normal Tension Glaucoma; Low-Tension Glaucoma, Bilateral; Low-Tension Glaucoma, Unspecified Eye; Glaucoma Interventions: Drug: QLS-111 ophthalmic solution, (0.015%); Drug: QLS-111 ophthalmic solution, (0.03%); Other: QLS-111 ophthalmic vehicle solution Sponsor: Qlaris Bio, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials